This past week, the CBSA team represented our community at the BIO International Convention, shared our expertise on the Colorado Prescription Drug Affordability Board (PDAB) during a webinar hosted by the Coalition of State Rheumatology Organizations (CSRO), and tracked several key federal issues, including Most-Favored-Nation (MFN) drug pricing and HHS Secretary Robert F. Kennedy Jr.’s actions related to vaccines. Read today’s policy blog for a news roundup.
BIO International Convention: Elyse Blazevich, CBSA President and CEO, and Matt Teter, CBSA Vice President of Partnerships, were proud to champion Colorado’s life sciences community this past week at the Biotechnology Innovation Organization (BIO) International Convention in Boston. The CBSA team supported members of our life sciences ecosystem; connected with companies, investors, and talent considering Colorado; and attended a variety of informative and…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
